ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co Ltd
Cash Paid for Dividends
ZhuZhou QianJin Pharmaceutical Co Ltd
Cash Paid for Dividends Peer Comparison
600436
600276
000538
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
|
Cash Paid for Dividends
-¥148.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash Paid for Dividends
-¥652.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash Paid for Dividends
-¥785.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-22%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash Paid for Dividends
-¥2.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-24%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash Paid for Dividends
-¥18.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ZhuZhou QianJin Pharmaceutical Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-148.4m
CNY
Based on the financial report for Mar 31, 2024, ZhuZhou QianJin Pharmaceutical Co Ltd's Cash Paid for Dividends amounts to -148.4m CNY.
What is ZhuZhou QianJin Pharmaceutical Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-6%
Over the last year, the Cash Paid for Dividends growth was 40%. The average annual Cash Paid for Dividends growth rates for ZhuZhou QianJin Pharmaceutical Co Ltd have been 13% over the past three years , -7% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
